Subscribe to Newsletter

Jean-Paul Kress

The Power List 2021 – Biopharmaceuticals

CEO at MorphoSys

“One lesson from COVID-19 is the idea that scientists in industry, academia, and government can coordinate activities better and work more openly together to rapidly develop transformational medicines in the future. Such collaborations should have impacts far beyond pandemics to provide patients with better treatments for life-threatening diseases such as cancer. At MorphoSys, we’ve learned that including innovative clinical strategies with real-world evidence studies and pursuing accelerated pathways for breakthrough medicines can lead to accelerated drug development and approval.”

Since joining MorphoSys as CEO in September 2019, Kress has strategically repositioned the company from an antibody technology provider to a commercial-stage biopharma company.

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine